B

Bavarian Nordic A/S
CSE:BAVA

Watchlist Manager
Bavarian Nordic A/S
CSE:BAVA
Watchlist
Price: 204 DKK 1.95% Market Closed
Market Cap: 16B DKK
Have any thoughts about
Bavarian Nordic A/S?
Write Note

Bavarian Nordic A/S
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Bavarian Nordic A/S
Revenue Peer Comparison

Comparables:
GMAB
ZEAL
ASND
F
FLUO
BIOPOR

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
B
Bavarian Nordic A/S
CSE:BAVA
Revenue
kr6.1B
CAGR 3-Years
53%
CAGR 5-Years
57%
CAGR 10-Years
19%
Genmab A/S
CSE:GMAB
Revenue
kr19B
CAGR 3-Years
37%
CAGR 5-Years
43%
CAGR 10-Years
39%
Zealand Pharma A/S
CSE:ZEAL
Revenue
kr76.9m
CAGR 3-Years
-22%
CAGR 5-Years
12%
CAGR 10-Years
-7%
Ascendis Pharma A/S
NASDAQ:ASND
Revenue
€317.6m
CAGR 3-Years
297%
CAGR 5-Years
75%
CAGR 10-Years
32%
F
Fluoguide AS
STO:FLUO
Revenue
kr0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bioporto A/S
CSE:BIOPOR
Revenue
kr33.8m
CAGR 3-Years
11%
CAGR 5-Years
4%
CAGR 10-Years
6%

See Also

What is Bavarian Nordic A/S's Revenue?
Revenue
6.1B DKK

Based on the financial report for Jun 30, 2024, Bavarian Nordic A/S's Revenue amounts to 6.1B DKK.

What is Bavarian Nordic A/S's Revenue growth rate?
Revenue CAGR 10Y
19%

Over the last year, the Revenue growth was 10%. The average annual Revenue growth rates for Bavarian Nordic A/S have been 53% over the past three years , 57% over the past five years , and 19% over the past ten years .

Back to Top